Solicitor General D. John Sauer is urging the Supreme Court to deny AstraZeneca’s petition to hear the constitutionality of ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...

The legal action comes days after Merck & Co. filed suit calling the mandate 'unconstitutional.' The U.S. Chamber of Commerce on Friday filed suit against the federal government, claiming that the ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

Three federal courts reject legal challenges to Medicare drug price negotiation Judges side with government in cases filed by Boehringer Ingelheim, PhRMA, and the U.S. Chamber of Commerce Rulings ...

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...

An appeals court has ruled against a legal challenge to the Drug Price Negotiation Program. On Wednesday, the U.S. Court of Appeals for the Sixth Circuit sided with the Department of Health and Human ...

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The ...

President Donald Trump‘s $3.3 trillion domestic agenda bill, passed by House Republicans on Thursday, includes a significant but little-noticed victory for pharmaceutical companies that will cost ...

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...